Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Inventory (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Change in Inventory for 16 consecutive years, with -$57779.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Inventory rose 84.66% year-over-year to -$57779.0, compared with a TTM value of -$890206.0 through Sep 2025, up 34.28%, and an annual FY2024 reading of -$1.6 million, down 9520.14% over the prior year.
  • Change in Inventory was -$57779.0 for Q3 2025 at China Pharma Holdings, up from -$164804.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $552686.0 in Q1 2023 and bottomed at -$679042.0 in Q2 2021.
  • Average Change in Inventory over 5 years is -$193160.5, with a median of -$211393.0 recorded in 2021.
  • The sharpest move saw Change in Inventory tumbled 6335.2% in 2021, then skyrocketed 311.81% in 2022.
  • Year by year, Change in Inventory stood at -$255815.0 in 2021, then rose by 24.59% to -$192902.0 in 2022, then crashed by 34.09% to -$258659.0 in 2023, then crashed by 97.56% to -$510996.0 in 2024, then surged by 88.69% to -$57779.0 in 2025.
  • Business Quant data shows Change in Inventory for CPHI at -$57779.0 in Q3 2025, -$164804.0 in Q2 2025, and -$156627.0 in Q1 2025.